BRCA1 and breast carcinoma: Of them, 11 was irrelevant to 1298A>C polymorphism, four focused on breast cancer mortality, one conducted among the same patients and controls with another study, but provided less completed data, and for one study, the controls were chosen from BRCA1 carriers.